PubMed · 11476458
FDA panel recommends OTC status for second-generation antihistamines.
Abstract
The source did not provide an abstract. Follow the original record for more information.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
G Rollins. 2001. FDA panel recommends OTC status for second-generation antihistamines.. https://doi.org/10.1016/s1081-1206(10)62313-7
Cite the original work for its findings. Save a collection to share your selection of sources.